Impact of Combined Antiretroviral Therapy (cART) on AIDS-Related Lymphoma (ARL) Biology

被引：0
|
作者：
Rahn, Heidi
Lewis, Natasha
Mitsios, John V.
Mathew, Susan
Chadburn, Amy
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1468
引用
收藏
页码：372A / 372A
页数：1
相关论文
共 50 条
  • [1] Impact of Combined Antiretroviral Therapy (cART) on AIDS-Related Lymphoma (ARL) Biology
    Rahn, Heidi
    Lewis, Natasha
    Mitsios, John V.
    Mathew, Susan
    Chadburn, Amy
    LABORATORY INVESTIGATION, 2016, 96 : 372A - 372A
  • [2] A report of AIDS-related lymphoma (ARL) in Korea.
    Kim, Jin-Soo
    Kim, Seok Jin
    Kim, Jin Seok
    Min, Yoo Hong
    Lee, Moon Hee
    Bang, Soo-Mee
    Kim, Jeong A.
    Chi, Hyun-Sook
    Jang, Seong Soo
    Park, Chan Jeoung
    Suh, Cheolwon
    Kim, Chul Soo
    BLOOD, 2006, 108 (11) : 254B - 254B
  • [3] Influence of highly active antiretroviral therapy (HAART)on the prevalence and outcome of AIDS-related non-Hodgkin's lymphoma (ARL).
    van Dillen, NMA
    Roozendaal, KJ
    Mulder, JW
    van Oers, RHJ
    Frissen, JHJ
    Kersten, MJ
    BLOOD, 2001, 98 (11) : 347A - 347A
  • [4] Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma
    Navarro, JT
    Ribera, JM
    Oriol, A
    Romeu, J
    Sirera, G
    Mate, JL
    Batlle, M
    Xicoy, B
    Grau, J
    Millá, F
    Feliu, E
    LEUKEMIA & LYMPHOMA, 2002, 43 (09) : 1837 - 1842
  • [5] Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
    Besson, C
    Goubar, A
    Gabarre, J
    Rozenbaum, W
    Pialoux, G
    Châtelet, FP
    Katlama, C
    Charlotte, F
    Dupont, B
    Brousse, N
    Huerre, M
    Mikol, J
    Camparo, P
    Mokhtari, K
    Tulliez, M
    Salmon-Céron, D
    Boué, F
    Costagliola, D
    Raphaël, M
    BLOOD, 2001, 98 (08) : 2339 - 2344
  • [6] CHARACTERISTICS AND OUTCOMES OF AIDS-RELATED LYMPHOMA (ARL) PATIENTS AFTER INTRODUCTION OF HIGH ACTIVE ANTIRETROVIRAL THERAPY. EXPERIENCE OF TWO INSTITUTIONS
    Gracia, E.
    Jimenez, N.
    Areces, F.
    Diaz, C.
    Calas, B.
    Capo, V.
    Perez, L.
    Jimenez, J.
    Perez, A.
    Morales, E.
    Pacheco, B.
    Fleites, G.
    ANNALS OF ONCOLOGY, 2011, 22 : 236 - 236
  • [7] Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)
    A Krishnan
    J Zaia
    J Alvarnas
    N Kogut
    J Cai
    A Nademanee
    J Palmer
    N Tsai
    SJ Forman
    Infectious Agents and Cancer, 4 (Suppl 2)
  • [8] AIDS-related lymphoma (ARL) in Asians in the era of HAART and rituximab.
    Tan, Wu Meng
    Tan, Soo Yong
    Ng, Tat Ming
    Pan, Summer
    Quek, Richard Hong Hui
    Tao, Miriam
    Tai, Wai Meng David
    Koh, Yin Ling
    Tan, Thuan Tong
    Tan, Daryl C. L.
    Ha, Tam Cam
    Chan, Alexandre
    Tay, Kevin
    Lim, Soon Thye
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] AIDS-related non-Hodgkin's lymphoma: Etiology, epidemiology, and impact of highly active antiretroviral therapy
    Little, RF
    LEUKEMIA & LYMPHOMA, 2003, 44 : S63 - S68
  • [10] Clinical and inununologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy
    Barclay, Lindsay R.
    Buskin, Susan E.
    Kahle, Erin M.
    Aboulafia, David M.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (04): : 272 - 279
12345